Tatva Chintan Pharma Chem Ltd presented its financial results for the quarter and nine months ending December 31, 2024, highlighting a 7% YoY increase in revenue from operations to 2,952 million and a 77% YoY growth in PAT.
AI Assistant
Tatva Chintan Pharma Chem Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.